Emergency department visits attributed to selected analgesics, United States, 2004-2005

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 3, 2009, Pages 188-195

  Willy, Mary E ^a,e   Kelly, Judith P ^b   Nourjah, Parivash ^c   Kaufman, David W ^b   Budnitz, Daniel S ^d   Staffa, Judy ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b BOSTON UNIVERSITY   (United States)

^c AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e NONE   (United States)

Author keywords

Adverse events; Analgesics; Emergency department

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; IBUPROFEN; NAPROXEN; NARCOTIC AGENT; PARACETAMOL;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; AUTOMUTILATION; CHILD; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG RESPONSE; DRUG SURVEILLANCE PROGRAM; DRUG TREATMENT FAILURE; DRUG USE; EMERGENCY WARD; EPIDEMIOLOGICAL DATA; FALLING; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; UNITED STATES; AGE; DRUG UTILIZATION; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; MIDDLE AGED; NEWBORN; STATISTICS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE SURVEYS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; UNITED STATES;

EID: 65249098556     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1691     Document Type: Article

References (23)

1. Paulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 2003; 12: 315-326.
2. Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adults. Pharmacoepidemiol Drug Saf 2005; 14: 257-266.
3. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 2002; 287: 337-344.
4. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antinflammatory drugs. N Engl J Med 1999; 340: 1888-1899.
5. Lewis JD, Kimmel SE, Localio AR, et al. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 2005; 128: 1865-1874.
6. Thomas J, Straus WL, Bloom BS. Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms. Am J Gastroenterol 2002; 97: 2215-2219.
7. American Academy of Pediatrics: Committee on Drugs. Acetaminophen toxicity in children. Pediatrics 2001; 108: 1020-1023.
8. Schiødt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997; 337: 1112-1117.
9. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364-1372.
10. Budnitz DS, Pollock DA,Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatients adverse drug events. JAMA 2006; 296: 1858-1866.
11. Lai MW, Klein-Schwartz W, Rodgers GC, et al. 2005 annual report of the American Association of Poison Control Centers National Poisoning and Exposure Database. Clin Tox 2006; 44: 803-932.
12. Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (paracetamol)-associated overdoses in the United States. Pharmacoepidemol Drug Saf 2006; 15: 398-405.
13. Consumer Product Safety Commission. National Electronic Injury Surveillance System All Injury Program Sample Design and Implementation. U.S. Consumer Product Safety Commission: Washington, D.C., 2002.
14. Jhung MA, Budnitz DS, Mendelsohn AB,Weidenbach KN, Nelson TD, Pollock DA. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (NEISS-CADES) Medical Care. 2007; 24 (suppl 2): S96-S102.
15. Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. Ann Emerg Med. 2005; 45: 197-206.
16. Kelly JP, Cook SF, Kaufman DW, Anderson TE, Rosenberg L,Mitchell AA. Prevalence and characteristics of opioid use in the U.S. adult population. Pain 2008; 138: 507-513.
17. The American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys (3rd edn), AAPOR: Lenexa, Kansas, 2004. 1-42
18. Cohen AL, Budnitz DS,Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr 2008; 152: 416-421.
19. McCaig LF, Burt CW. Poisoning-related visits to emergency departments in the United States, 1993-1996. Clin Tox 1999; 37: 817-826.
20. Rivera-Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130: 300-304.
21. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemol Drug Saf 2006; 15: 618-627.
22. O'Rourke D, Johnson T. An inquiry into declining RDD response rates. Part III: a multivariate review. Survey Res 1999; 2-3: 1-3.
23. U.S. Department of Health and Human Services: Food and Drug Administration. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use: proposed amendment of the tentative final monograph: required warnings and other labeling. Federal Register 2006; 71: 77314-77352.